Skip to main content
. 2012 Mar 9;19(7):2246–2255. doi: 10.1245/s10434-012-2260-3

Table 4.

Information at the time of detection of PR

Clinicopathologic factors Unresectable PR Resectable PR P
(n = 23) (n = 13)
Interval between hepatectomy and PR, mo, median (range) 6.0 (1.0–43.0) 11.0 (1.0–102.0) 0.009*
Interval between hepatectomy and peritoneal
 Recurrence
  ≤6 month 13 (56.5%) 5 (38.4%) 0.080
  >6 month 10 (43.4%) 8 (61.5%)
Tumor markers at PR
 AFP level, mean ± SD 16519.7 ± 45832.1 575.4 ± 1475.2 0.032*
AFT level
 ≤200 ng/dl 13 (56.5) 10 (76.9) 0.221
 >200 ng/dl 10 (43.5) 3 (23.1)
PIVKA-II level
 Mean ± SD 407.0 ± 498.1 180.5 ± 348.8 0.034*
  ≤200 mAU/ml 11 (55.0) 10 (83.3) 0.102
  >200 mAU/ml 9 (45.0) 2 (16.7)
No. of peritoneal lesions, median (range) 2.0 (1.0–7.0) 1.0 (1.0–4.0) 0.044*
 Single lesion 6 (26.1%) 7 (53.8%) 0.096
 Multiple lesions 17 (73.9%) 6 (46.2%)  
Size of largest peritoneal lesion
 Median (range), mm 24.0 (4.0–60.0) 35.0 (10.0–140.0) 0.070
 ≤30 mm 16 (69.6) 7 (30.4) 0.069
 >30 mm 5 (38.5) 8 (61.5)
Total size of peritoneal lesion
 Median (range), mm 47.0 (20.0–255) 60.0 (10.0–140.0) 0.499
 ≤50 mm 14 (60.9) 9 (39.1) 0.196
 >50 mm 5 (38.5) 8 (61.5)  
Location of PR
 Omentum 17 (73.9%) 0 (0.0%) <0.001*
 Posterior peritoneum 4 (17.4%) 7 (53.8%)
 Anterior peritoneal/ abdominal wall 2 (8.7%) 2 (15.4%)
 Combination 0 (0.0%) 4 (30.8%)
 Posterior peritoneum with omental nodules 3 (23.1%)
 Posterior peritoneum with chest wall 1 (7.7%)
Omental seeding 17 (73.9%) 3 (23.1%) <0.003*
Other 6 (26.1%) 10 (76.9%)  

* Statistically significant at P < 0.05